Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017

Amphastar Pharmaceuticals (AMPH) PT Lowered to $19 at Jefferies Following Strong 2Q

August 11, 2017 8:22 AM EDT

Jefferies lowered its price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $19.00 (from $20.00) while maintaining a Buy rating following the company's 2Q. AMPH reported EPS of $0.11, exceeding estimates by $0.07 driven by a topline of ~$65M, which topped forecasts by $5.2M.

Management appears more... More